Objective: The development of acute kidney injury (AKI) and its effect on prognosis after lower extremity bypass (LEB) surgery have not been well described. We determined risk factors associated with AKI in patients undergoing infrainguinal LEB surgery and whether individuals with AKI are at increased risk for cardiovascular events and mortality.
Individuals with symptomatic peripheral artery disease (PAD) and concomitant renal insufficiency are at risk for increased perioperative morbidity and mortality after lower extremity surgical revascularization; however, postoperative data on the incidence and prognosis of acute kidney injury (AKI) after lower extremity bypass (LEB), irrespective of baseline renal function, are lacking. 1 Several factors place patients at risk for AKI at the time of LEB, including the occurrence of hypotension, increased levels of circulating catecholamines and inflammatory mediators, oxidative stress, administration of nephrotoxic agents, such as antibiotics, and underlying renal hypoperfusion from atherosclerotic renovascular disease.
Postoperative AKI has been reported to complicate as many as 50% of all vascular procedures and is independently associated with a prolonged hospital stay, increased perioperative mortality, and decreased longterm survival. 2, 3 Risk for AKI is not uniform, however, across all vascular procedures and may differ according to the anatomic location or whether the procedure is open or endovascular. For example, the need for aortic cross-clamping during aortic surgery and the use of significant intraprocedural contrast during endovascular procedures are major risk factors for AKI that do not apply to LEB. [4] [5] [6] [7] The available literature regarding AKI after LEB specifically is limited and comes from small, relatively nondiverse patient populations. [8] [9] [10] Although findings from these smaller studies suggest that postoperative AKI in patients undergoing LEB is common and associated with poorer outcomes, corroborating these findings in a large multicenter, diverse patient population is important. The Society for Vascular Surgery (SVS) Vascular Quality Initiative (VQI) registry was used to (1) determine the incidence of and risk factors associated with AKI development in PAD patients undergoing infrainguinal LEB and (2) determine whether postoperative AKI is associated with an increased risk of inpatient cardiovascular and limb events, inpatient mortality, and long-term mortality.
METHODS
Study participants. We performed a retrospective observational study in the VQI registry. The SVS launched the VQI with the aim to improve vascular health care through the collection and exchange of information among regional quality groups. 11 Physicians and other hospital personnel enter baseline patient demographic and clinical variables as well as procedural and postoperative variables into a Web-based data collection platform. Because the data are collected under the auspices of the SVS Patient Safety Organization, requirements for patient consent were waived. In-depth information about the SVS-VQI can be found at www. vascularqualityinitiative.org. This study was approved by the SVS-VQI Research Advisory Committee. Data are provided in an unlinked, deidentified manner and are exempt from further human use review by the Institutional Review Board. All patients undergoing infrainguinal LEB for any indication, including elective and emergency surgery, were included. From January 2012 through April 2015, 16,714 consecutive operations in 15,205 patients were performed across 350 academic and community hospitals and 45 states. Records in the VQI database correspond to individual operations; thus, a patient with multiple operations contributes one record per operation. Eligible operations included those performed on (1) patients aged $18 years at the time of surgery, (2) without stage 5 chronic kidney disease (CKD), without a transplanted kidney or being on dialysis before surgery, (3) with available data on preoperative serum creatinine and postoperative change in serum creatinine, and (4) with complete data for all demographic, clinical, and perioperative variables of interest. Operations occurring before January 2012 were not included in the analysis because of the high degree of missing data. Of the 6528 operations that were performed between January 2006 and December 2011, 6391 would have been excluded due to missing data. Only 132 operations would have met eligibility criteria for this study and this would have contributed to <1% of the included procedures.
Patient data. Demographic information on age, gender, and race (white, Hispanic, non-Hispanic black, and other) were recorded. Clinical characteristics recorded at baseline included American Society of Anesthesiologists (ASA) Physical Status Classification, body mass index, chronic obstructive pulmonary disease, coronary heart disease, congestive heart failure (CHF), critical limb ischemia (CLI), diabetes, hypertension, and tobacco use (before or current). Coronary heart disease was defined as a history of coronary artery bypass grafting, percutaneous coronary intervention, myocardial infarction (MI), stable or unstable angina, or a documented stress test positive for ischemia or infarction. CLI was defined as a surgical indication for LEB involving rest pain, tissue loss, or acute ischemia.
Medications recorded at baseline included use of antiplatelet, angiotensin-converting enzyme (ACE) inhibitor, angiotensin receptor blocker (ARB), b-blocker, and statin agents. b-Blocker use was further categorized according to when the medication was initiated in reference to the date of surgery (operative day only, 1-30 days before surgery, and >30 days before surgery).
Preoperative laboratory measures of interest were serum creatinine and hemoglobin. The estimated glomerular filtration rate was derived using the abbreviated Modification of Diet in Renal Disease equation, and CKD stage was subsequently determined. [12] [13] [14] Preoperative testing involving contrast use with a lower extremity arteriogram (yes/no) or computed tomography angiogram (yes/no) was also noted. Procedurally related variables recorded were need for emergency surgery, procedure time, completion arteriogram involving contrast use, preoperative use of antibiotics, need for blood transfusion, development of infection (graft-related, wound-related, or pneumonia), and respiratory failure requiring mechanical ventilation. Antibiotic use was further stratified into cephalosporin based or noncephalosporin based. Transfusion was defined as requiring at least 3 units of packed red blood cells to better capture the need for transfusion resulting from clinically significant bleeding rather than baseline anemia.
Study end points. AKI during hospitalization was defined as a postoperative absolute rise in creatinine >0.5 mg/dL or new renal impairment requiring dialysis. Cardiovascular events occurring during inpatient hospitalization were clinically significant arrhythmia, MI, CHF, and stroke. Arrhythmia was defined as a new rhythm disturbance requiring treatment with medications or cardioversion. MI was defined as electrocardiogram changes or clinical evidence of MI in conjunction with any abnormality of cardiac biomarker consistent with infarction (creatine kinase-MB or troponin). CHF was defined as the presence of pulmonary edema requiring monitoring or treatment in the intensive care unit or step-down unit. Postoperative stroke was not specifically defined and was determined by treating physician judgment. Limb events occurring during inpatient hospitalization included above-ankle amputation and loss of primary graft patency.
Inpatient and long-term mortality were assessed. Inpatient mortality was defined as death occurring during the procedure or before hospital discharge. Long-term mortality was assessed up to July 1, 2015, and determined by query of the Social Security Death Index or by longterm follow-up by the performing institution.
Statistical analysis. Comparison of univariate baseline characteristics between those who did and did not develop AKI after the procedure performed using Pearson c 2 tests for categoric variables and t-tests for continuous variables with individual patients as the unit of analysis. For the multivariate analyses, special methods that can deal with clustered/correlated observations are required because an individual with multiple operations contributes multiple non-independent observations. We used generalized estimating equations (GEE) logistic regression to assess (1) demographic, preoperative. and postoperative AKI determinants and (2) effect of AKI on the risk of adverse cardiovascular events, adverse limb events, and inpatient mortality. 15 We used an independent structure for the working covariance matrix of the logistic regression GEE model. The analyses were adjusted for common demographic and baseline clinical variables in addition to variables a priori believed to be potential confounders for the specific outcome. For the long-term survival analysis, individual patients rather than individual procedures were the unit of analysis. For patients with multiple procedures, we considered survival after the patient's last recorded procedure. We used standard Cox regression for this analysis. In addition to demographic and baseline clinical variables, we adjusted for any previous procedures by including the number of previous infrainguinal procedures (ranging from 0 to 5 procedures) as an adjustment covariate. To adjust for AKI that developed at any previous procedure (previous to the last procedure at which the "survival clock" starts counting), we included as covariate a variable indicating whether AKI was developed after any previous infrainguinal procedure the patient had. To determine whether the effect of AKI on patient outcomes might differ in patients undergoing LEB in the presence of CLI, a P value for interaction between incident AKI and CLI was performed separately Comparisons were made between patients with and without AKI.
for each outcome (cardiovascular events, adverse limb events, inpatient mortality, and long-term mortality). Analyses were performed using R 3.2.2 software (The R Foundation for Statistical Computing, http://www. r-project.org/foundation/). The GEE analyses were performed using "geepack" package in R 1.2 software.
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RESULTS
Of the 16,714 operations performed between January 2012 and April 2015, 3807 were sequentially excluded in patients for the following reasons: (1) patient was not aged $18 years when the procedure occurred (n ¼ 123), (2) presence of stage 5 CKD, a transplanted kidney, or dialysis before surgery (n ¼ 1175), (3) missing data on serum creatinine (n ¼ 130), and (4) missing data for demographic, clinical, or perioperative variables of interest (n ¼ 2379). After appropriate exclusions were made, 12,907 operations remained, corresponding to 11,859 patients, and were included in the analysis. AKI developed after 507 LEB operations (4%) performed in 470 patients. There were 99 deaths (<1%) during the index hospitalization, and 862 deaths (7%) occurred overall during a median follow-up of 11.5 months (interquartile range, 16.4 months). Baseline and perioperative characteristics in patients undergoing LEB compared according to AKI development are reported in Table I .
Multivariate analyses were used to determine demographic, clinical, and perioperative patient characteristics associated with the development of AKI after LEB (Table II) . Male gender, CHF, CLI, diabetes, and ACE inhibitor or ARB use were associated with a higher risk of incident AKI. Higher estimated glomerular filtration rate, higher hemoglobin levels, and former or current tobacco use were associated with a lower risk of incident AKI. Perioperative characteristics associated with an Table III reports the multivariate adjusted risk ratios for inpatient and long-term mortality associated with the development of AKI after LEB. After adjustment for demographic, clinical, and perioperative characteristics, incident AKI after LEB was associated with a significantly increased risk of inpatient mortality (odds ratio [OR], 6.96; 95% confidence interval [CI], 3.94-12.31) and longterm mortality (hazard ratio, 1.98; 95% CI, 1.58-2.47). P values for the interaction between incident AKI and CLI for the outcomes of inpatient mortality and long-term mortality outcome were not significant (P ¼ .49 and P ¼ .38, respectively).
There were 777 cardiovascular events and 633 limbrelated events postoperatively during the index hospitalization. Table IV reports adjusted ORs for major adverse cardiovascular and limb events associated with the development of AKI after LEB. Adjusting for the same demographic, clinical, and perioperative characteristics, only the association between incident AKI and increased risk of cardiovascular events was significant (OR, 2.50; 95% CI, 1.91-3.28). No significant P value for interaction was noted between incident AKI and CLI for risk of cardiovascular events (P ¼ .34) or limb events (P ¼ .69).
DISCUSSION
In this large, retrospective analysis of individuals with PAD undergoing infrainguinal LEB, postoperative AKI was associated with an increased risk of short-term cardiovascular events and death, even after adjustment for baseline and perioperative variables. This increased risk of mortality remained significant over the course of follow-up. We found that the baseline risk factors for incident AKI included male gender, CHF, CLI, diabetes, and ACE inhibitor or ARB use, and perioperative risk factors included emergency surgery, infection, requiring blood transfusion, respiratory failure, and isolated b-blocker use on the day of surgery. Better renal function, higher hemoglobin, and tobacco use conferred a lower risk of incident AKI. Predictors of AKI reported in this study are similar to those reported in other studies of individuals undergoing cardiac or noncardiac surgery.
17 Surprisingly, we found tobacco use was protective for AKI in our study. There is no clear hypothesis to explain why smoking would be a negative risk factor and is not consistent with previous studies suggesting epidemiologic and mechanistic associations between tobacco use and kidney injury. [18] [19] [20] [21] To our knowledge, this is the first study to report an association with incident AKI after LEB and an increased risk of short-term cardiovascular events and mortality. Prior studies have also reported an increased risk in all-cause mortality over long-term follow-up associated with postoperative AKI after LEB, but they had a small number of patients and lacked patient diversity. 9, 10 Among 700 male patients in a Veterans Affairs Medical Center undergoing lower extremity revascularization, less than one-third of which were surgical bypass, postprocedural AKI developed in 12% of patients and was associated with a nearly twofold increased risk of all-cause mortality. 8, 10 In another single-center study of predominantly white individuals undergoing LEB or abdominal aortic surgery, postoperative AKI was associated with a 24% increase in all-cause mortality. 9 Our findings, therefore, build significantly on the available literature and establish the increased morbidity and mortality associated with the presence of AKI after LEB. The increased long-term mortality risk associated with postoperative AKI observed in our study is particularly important considering the higher mortality rates in individuals with PAD compared with those without PAD. 22 Individuals with intermittent claudication have a 5-year mortality of 15% to 30%, and those with CLI have a 1-year mortality as high as 25%. 23 Chronic renal insufficiency is associated with increased long-term mortality among individuals with symptomatic PAD, and the persistently increased mortality risk beyond hospital discharge associated with AKI seen in our study may be explained by the development of subsequent CKD. 24, 25 Individuals who experience reversible, hospital-associated AKI have a 90% increased risk of developing CKD compared with those who maintain normal renal function throughout their hospitalization. 26 In addition, AKI, even when reversible, may result in permanent injury to vital organs and adversely affect future survival. Experimental animal studies demonstrate AKI induces tissue injury in multiple organs, resulting in cardiac apoptosis and loss of pulmonary vascular integrity. 27, 28 Although no prior studies have reported a relationship between incident AKI and increased adverse cardiovascular events in individuals specifically undergoing LEB, this association has been demonstrated in individuals undergoing cardiac and other types of vascular surgery. [29] [30] [31] Several pathophysiologic mechanisms may help to explain how AKI contributed to an increased risk of acute cardiovascular events in our study, including increases in inflammatory cytokine levels, activation of the renin-angiotensin-aldosterone system causing water, salt, and vasoconstrictor disturbances, and acute fluid retention precipitating unstable heart function.
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The rate of AKI after LEB in our study was significantly lower than prior studies of similar populations.
9,10 The definition of AKI was limited to a peak absolute rise in serum creatinine of 0.5 mg/dL, which was higher than the 0.3 mg/dL level recommended by the Acute Kidney Injury Network. 36 In addition, other criteria recommended by this network to diagnose AKI, including relative increases in baseline creatinine to peak creatinine and urine output, were not available in the database and therefore could not be used in our analysis. Our study may have underestimated the true incidence of AKI after LEB, and milder cases of AKI may not have been captured adequately. Other limitations were also present. Causality cannot be inferred on the basis of this observational study, and we cannot exclude the possibility that unmeasured or unidentified confounders may account for the observed associations. The temporal relationship between perioperative characteristics and the development of AKI was not known, and it is possible that need for blood transfusion, presence of infection, or development of respiratory failure occurred after AKI was present and not before. Similarly, although we evaluated risk associated with arteriography and computed tomography angiography in the development of postoperative AKI, we did not know the amount of contrast used or the interval between testing and surgery. Because actual postoperative creatinine values were not recorded, the effect of AKI severity on study end points could not be assessed. History of stroke and baseline cholesterol levels were not known and could not be accounted for in adjusted associations between incident AKI and study end points.
CONCLUSIONS
AKI after LEB is associated with an increased risk of inpatient cardiovascular events and death. Increased mortality risk remained significant throughout the length of followup. Identifying approaches to decrease the risk of perioperative AKI based on the presence of underlying predictors is highly important in this population. Prospective or randomized studies are needed to determine whether certain interventions can reduce AKI incidence and subsequent risk on morbidity and mortality.
